Ellervik, Ulf,Sterner, Olov,Strevens, Helena,Manner, Sophie
申请号：
AU2017248050
公开号：
AU2017248050A1
申请日:
2017.04.06
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone,wherein the glucono δ-lactoneis present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
